ABT-450/Ritonavir/ABT-267
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ABT-450/Ritonavir/ABT-267, covering 2015-01-06 to 2017-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt [Phase 3]